Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response.
Suzanne Louise Topalian
Consultant or Advisory Role - Amplimmune (I); Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
Julie R. Brahmer
No relevant relationships to disclose
F. Stephen Hodi
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
David C. Smith
Research Funding - Bristol-Myers Squibb
Scott N. Gettinger
No relevant relationships to disclose
Janis M. Taube
Research Funding - Bristol-Myers Squibb
Charles G. Drake
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Dendreon
Stock Ownership - Amplimmune
Other Remuneration - Bristol-Myers Squibb
Drew M. Pardoll
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb (U)
Scott Antonia
No relevant relationships to disclose
David R. Spigel
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Michael B. Atkins
Consultant or Advisory Role - Bristol-Myers Squibb; CureTech; Merck
Donald P. Lawrence
No relevant relationships to disclose
Dan McDonald
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Maria Jure-Kunkel
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Alan Korman
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Georgia Kollia
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (B)
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jon Wigginton
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Mario Sznol
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb